¼¼°èÀÇ Ç÷¾× Áø´Ü ½ÃÀå
Hematology Diagnostics
»óǰÄÚµå : 1760880
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 174 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,106,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,320,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Ç÷¾× Áø´Ü ¼¼°è ½ÃÀåÀº 2030³â±îÁö 119¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 85¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â Ç÷¾× Áø´Ü ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 5.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 119¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼Ò¸ðǰÀº CAGR 5.4%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 78¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±â±â ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 6.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 22¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Ç÷¾× Áø´Ü ½ÃÀåÀº 2024³â¿¡ 22¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 9.2%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿© 2030³â±îÁö 27¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.0%¿Í 4.9%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.9%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ Ç÷¾× Áø´Ü ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Ç÷¾× Áø´ÜÀÌ Çö´ë ÀÇ·á¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀϱî?

Ç÷¾× Áø´ÜÀº ºóÇ÷, °¨¿°, ¹éÇ÷º´°ú °°Àº Ç÷¾× ¾Ç¼º Á¾¾ç°ú °°Àº Ç÷¾× °ü·Ã ÁúȯÀÇ Áø´Ü ¹× ¸ð´ÏÅ͸µ¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â Ç÷±¸ ¼ö, ÀÀ°í »óÅÂ, ¼¼Æ÷ ÇüÅ¿¡ ´ëÇÑ ±ÍÁßÇÑ Á¤º¸¸¦ Á¦°øÇÏ¿© Áúº´ ¹ß°ß ¹× Ä¡·á ¸ð´ÏÅ͸µ¿¡ µµ¿òÀÌ µË´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ Á¶±â Áø´Ü°ú ¿¹¹æ ÀǷḦ ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥, Ç÷¾× Áø´ÜÀº ÀÌ»óÀ» Á¶±â¿¡ ¹ß°ßÇϰí Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÀϹÝÀûÀÎ °Ç°­ »óŸ¦ Æò°¡ÇÏ°í ½É°¢ÇÑ Áúº´À» Áø´ÜÇÏ´Â µ¥ ÀÖ¾î Ç÷¾×ÇÐÀÇ ¿ªÇÒ·Î ÀÎÇØ ÀÌ·¯ÇÑ Áø´Ü ¹æ¹ýÀº ÀÇ·á ½ÇÇè½ÇÀÇ ÁÖ¿ªÀÌ µÇ¾ú½À´Ï´Ù.

±â¼ú ¹ßÀüÀº Áø´Ü Á¤È®µµ¸¦ ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

Ç÷¾× Áø´ÜÀÇ ±â¼ú ¹ßÀüÀº °Ë»ç Á¤È®µµ, ¼Óµµ, ÀÚµ¿È­¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÚµ¿ ºÐ¼®±â´Â ÇöÀç ½Å¼ÓÇÏ°í ³ôÀº 󸮷®ÀÇ °á°ú¸¦ Á¦°øÇÏ¿© ¼öÀÛ¾÷À» ÁÙÀ̰í ÀÎÀû ¿À·ù¸¦ ÃÖ¼ÒÈ­Çϰí ÀÖ½À´Ï´Ù. À¯¼¼Æ÷ ºÐ¼® ¹× µðÁöÅÐ À̹Ì¡°ú °°Àº ±â¼ú Çõ½ÅÀ¸·Î »ó¼¼ÇÑ ¼¼Æ÷ ºÐ¼®ÀÌ °¡´ÉÇØÁ® º¸´Ù Á¤È®ÇÑ Áø´ÜÀ» ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿Ü·¡¿¡¼­ ºü¸¥ °á°ú¸¦ Á¦°øÇÏ¿© Àû½Ã¿¡ ÀÓ»óÀû ÆÇ´ÜÀ» ³»¸± ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ´Â Point-of-Care Ç÷¾×ÇÐ ºÐ¼® Àåºñµµ º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº Ç÷¾× Áø´ÜÀ» º¸´Ù ½±°í, È¿À²ÀûÀ̸ç, ½Å·ÚÇÒ ¼ö ÀÖ°Ô ¸¸µé¾î ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô ÇýÅÃÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

¿Ö ÇöÀå Ç÷¾× Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϴ°¡?

POC(Point-of-Care) Ç÷¾× Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä´Â ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ º¸´Ù ºü¸¥ Áø´ÜÀ» Á¦°øÇϰí ȯÀÚ °æÇèÀ» °³¼±ÇϰíÀÚ ÇÏ´Â ¿ä±¸¿¡ µû¶ó Áõ°¡Çϰí ÀÖÀ¸¸ç, POC Ç÷¾×ÇÐ °Ë»ç´Â ½Å¼ÓÇÑ °á°ú°¡ ÀÇ»ç °áÁ¤¿¡ ÇʼöÀûÀÎ Áø·á¼Ò³ª ÀÀ±Þ½Ç°ú °°Àº ÀüÅëÀûÀÎ °Ë»ç½Ç ÀÌ¿ÜÀÇ È¯°æ¿¡ ÀûÇÕÇÕ´Ï´Ù. ÈÞ´ë¿ë POC Àåºñ´Â ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ȯÀÚ °¡±îÀÌ¿¡¼­ °Ë»ç¸¦ ½Ç½ÃÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© Áï°¢ÀûÀÎ Ä¡·á¸¦ ÃËÁøÇÏ°í ¿©·¯ ¹ø ¿¹¾àÇÒ Çʿ䰡 ¾øµµ·Ï ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Á¢±Ù¼º°ú È¿À²¼ºÀ» ¿ì¼±½ÃÇÏ´Â ºÐ»êÇü ÀÇ·á ¹× È¯ÀÚ Á᫐ ¼Ö·ç¼ÇÀ¸·ÎÀÇ ±¤¹üÀ§ÇÑ Àüȯ°ú ÀÏÄ¡ÇÕ´Ï´Ù.

Ç÷¾× Áø´Ü ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

Ç÷¾× Áø´Ü ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÚµ¿ Áø´ÜÀÇ ¹ßÀü, ÇöÀå °Ë»ç(point-of-care) °Ë»çÀÇ Ã¤Åà Áõ°¡ÀÔ´Ï´Ù. ÇコÄÉ¾î ½Ã½ºÅÛÀÌ ¿¹¹æ ÀǷḦ Áß½ÃÇϸ鼭 Á¶±â ¹ß°ß¿¡ ´ëÇÑ ³ë·ÂÀÌ Ç÷¾×ÇÐ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀº Áø´ÜÀÇ Á¤È®¼º°ú ¼Óµµ¸¦ Çâ»ó½ÃÄÑ ÀÚµ¿ Ç÷¾×ÇÐ ½Ã½ºÅÛÀ» ÀÇ·á ½ÇÇè½Ç¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ¸¸µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇöÀåÁø´Ü(POC) Áø´ÜÀÇ Àαâ Áõ°¡´Â ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼­ºñ½º·ÎÀÇ ÀüȯÀ» ¹Ý¿µÇϰí ÀÖÀ¸¸ç, Ç÷¾× Áø´ÜÀÌ Çö´ë ÀÇ·áÀÇ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ ÁøÈ­Çϰí Àֱ⠶§¹®¿¡ ½ÃÀå È®´ë¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(Ç÷±¸¼ö, Ç÷¼ÒÆÇ ±â´É, Çì¸ð±Û·Îºó, ÀûÇ÷±¸ ¿ëÀû·ü), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø, Áø´Ü½ÇÇè½Ç, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 43°³»ç)

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Hematology Diagnostics Market to Reach US$11.9 Billion by 2030

The global market for Hematology Diagnostics estimated at US$8.5 Billion in the year 2024, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.8 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 9.2% CAGR

The Hematology Diagnostics market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Hematology Diagnostics Market - Key Trends & Drivers Summarized

Why Are Hematology Diagnostics Essential in Modern Healthcare?

Hematology diagnostics are critical in diagnosing and monitoring blood-related diseases, including anemia, infections, and hematological malignancies like leukemia. These tests provide valuable insights into blood cell counts, coagulation status, and cellular morphology, aiding in disease detection and treatment monitoring. As healthcare systems prioritize early diagnosis and preventive care, hematology diagnostics are essential in identifying abnormalities early, allowing for timely intervention. The role of hematology in assessing general health and diagnosing serious conditions has made these diagnostics a mainstay in medical laboratories.

How Are Technological Advancements Improving Diagnostic Accuracy?

Technological advancements in hematology diagnostics are enhancing test accuracy, speed, and automation. Automated analyzers now provide rapid, high-throughput results, reducing manual processes and minimizing human error. Innovations such as flow cytometry and digital imaging enable detailed cellular analysis, allowing for more precise diagnoses. Point-of-care hematology analyzers are also becoming popular, offering rapid results in outpatient settings and supporting timely clinical decisions. These advancements are making hematology diagnostics more accessible, efficient, and reliable, benefiting both patients and healthcare providers.

Why Is the Demand for Point-of-Care Hematology Diagnostics Increasing?

The demand for point-of-care (POC) hematology diagnostics is growing as healthcare providers seek to deliver faster diagnoses and improve patient experience. POC hematology tests are ideal for settings outside traditional laboratories, such as clinics and emergency rooms, where quick results are essential for decision-making. Portable POC devices enable healthcare providers to perform tests closer to the patient, facilitating immediate care and reducing the need for multiple appointments. This trend aligns with the broader shift toward decentralized healthcare and patient-centric solutions, which prioritize accessibility and efficiency.

What Drives the Growth of the Hematology Diagnostics Market?

The growth in the hematology diagnostics market is driven by increased demand for early disease detection, advancements in automated diagnostics, and the rising adoption of point-of-care testing. Early detection initiatives support demand for hematology tests as healthcare systems emphasize preventive care. Technological innovations are enhancing diagnostic accuracy and speed, making automated hematology systems essential in medical laboratories. Additionally, the growing popularity of POC diagnostics reflects a shift toward accessible, patient-centered care, further fueling market expansion as hematology diagnostics evolve to meet modern healthcare needs.

SCOPE OF STUDY:

The report analyzes the Hematology Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Instruments); Test Type (Blood Count, Platelet Function, Hemoglobin, Hematocrit); End-Use (Hospitals, Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â